G G Kovacs1,2, A Yousef2, S Kaindl1, V M Lee2, J Q Trojanowski2. 1. Institute of Neurology, Medical University of Vienna, Vienna, Austria. 2. Center for Neurodegenerative Disease Research, Institute on Aging and Department of Pathology and Laboratory Medicine of the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Abstract
AIMS: Ageing-related tau astrogliopathy (ARTAG) appears in subependymal, subpial, perivascular, white matter (WM) and grey matter (GM) locations. Physical effects, blood-brain barrier dysfunction and blood- or vessel-related factors have been considered as aetiology. As connexin-43 (Cx43) and aquaporin-4 (AQP4) are related to these, we hypothesized that their immunoreactivity (IR) varies with ARTAG in a location-specific manner. METHODS: We performed a morphometric immunohistochemical study measuring the densities of IR of Cx43, AQP4, AT8 (phospho-tau) and glial fibrillar acidic protein (GFAP). We analysed the amygdala and hippocampus in age-matched cases with (n = 19) and without (n = 20) ARTAG in each of the locations it aggregates. RESULTS: We show a dramatic increase (>6-fold; P < 0.01) of Cx43 density of IR in ARTAG cases correlating strongly with AT8 density of IR, irrespective of the presence of neuronal tau pathology or reactive gliosis measured by GFAP density of IR, in the GM. In contrast, AQP4 density of IR was increased only in the WM and GM, and was associated with increased AT8 density of IR only in WM and perivascular areas. DISCUSSION: Our study reveals distinctive astroglial responses in each of the locations associated with ARTAG. Our observations support the concept that factors related to brain-fluid interfaces and water-ion imbalances most likely play a role in the generation of ARTAG. As Cx43 is crucial for maintaining neuronal homeostasis, the ARTAG-dependent increase of Cx43 density of IR suggests that the development of ARTAG in the GM most likely indicates an early response to the degeneration of neurons.
AIMS: Ageing-related tau astrogliopathy (ARTAG) appears in subependymal, subpial, perivascular, white matter (WM) and grey matter (GM) locations. Physical effects, blood-brain barrier dysfunction and blood- or vessel-related factors have been considered as aetiology. As connexin-43 (Cx43) and aquaporin-4 (AQP4) are related to these, we hypothesized that their immunoreactivity (IR) varies with ARTAG in a location-specific manner. METHODS: We performed a morphometric immunohistochemical study measuring the densities of IR of Cx43, AQP4, AT8 (phospho-tau) and glial fibrillar acidic protein (GFAP). We analysed the amygdala and hippocampus in age-matched cases with (n = 19) and without (n = 20) ARTAG in each of the locations it aggregates. RESULTS: We show a dramatic increase (>6-fold; P < 0.01) of Cx43 density of IR in ARTAG cases correlating strongly with AT8 density of IR, irrespective of the presence of neuronal tau pathology or reactive gliosis measured by GFAP density of IR, in the GM. In contrast, AQP4 density of IR was increased only in the WM and GM, and was associated with increased AT8 density of IR only in WM and perivascular areas. DISCUSSION: Our study reveals distinctive astroglial responses in each of the locations associated with ARTAG. Our observations support the concept that factors related to brain-fluid interfaces and water-ion imbalances most likely play a role in the generation of ARTAG. As Cx43 is crucial for maintaining neuronal homeostasis, the ARTAG-dependent increase of Cx43 density of IR suggests that the development of ARTAG in the GM most likely indicates an early response to the degeneration of neurons.
Authors: Jimmy Stehberg; Rodrigo Moraga-Amaro; Christian Salazar; Alvaro Becerra; Cesar Echeverría; Juan A Orellana; Geert Bultynck; Raf Ponsaerts; Luc Leybaert; Felipe Simon; Juan C Sáez; Mauricio A Retamal Journal: FASEB J Date: 2012-06-04 Impact factor: 5.191
Authors: Helen Ling; Gabor G Kovacs; Jean Paul G Vonsattel; Karen Davey; Kin Y Mok; John Hardy; Huw R Morris; Thomas T Warner; Janice L Holton; Tamas Revesz Journal: Brain Date: 2016-10-25 Impact factor: 13.501
Authors: Gabor G Kovacs; Kinga Molnár; Lajos László; Thomas Ströbel; Gergö Botond; Selma Hönigschnabl; Angelika Reiner-Concin; Miklós Palkovits; Peter Fischer; Herbert Budka Journal: Acta Neuropathol Date: 2011-03-25 Impact factor: 17.088
Authors: Oliver Peters; Carola G Schipke; Andreas Philipps; Brigitte Haas; Ulrike Pannasch; Li Ping Wang; Bruno Benedetti; Ann E Kingston; Helmut Kettenmann Journal: J Alzheimers Dis Date: 2009 Impact factor: 4.472
Authors: Douglas M Zeppenfeld; Matthew Simon; J Douglas Haswell; Daryl D'Abreo; Charles Murchison; Joseph F Quinn; Marjorie R Grafe; Randall L Woltjer; Jeffrey Kaye; Jeffrey J Iliff Journal: JAMA Neurol Date: 2017-01-01 Impact factor: 18.302
Authors: Alan King Lun Liu; Marc H Goldfinger; Hayleigh E Questari; Ronald K B Pearce; Steve M Gentleman Journal: Acta Neuropathol Commun Date: 2016-06-13 Impact factor: 7.801
Authors: Shelley L Forrest; Jordan Hanxi Kim; Daniel R Crockford; Katharine Huynh; Rosie Cheong; Samantha Knott; Madison A Kane; Lars M Ittner; Glenda M Halliday; Jillian J Kril Journal: Neurochem Res Date: 2022-08-05 Impact factor: 4.414
Authors: John D Arena; Douglas H Smith; Edward B Lee; Garrett S Gibbons; David J Irwin; John L Robinson; Virginia M-Y Lee; John Q Trojanowski; William Stewart; Victoria E Johnson Journal: Brain Date: 2020-05-01 Impact factor: 13.501
Authors: Paul Denver; Heather D'Adamo; Shuxin Hu; Xiaohong Zuo; Cansheng Zhu; Chihiro Okuma; Peter Kim; Daniel Castro; Mychica R Jones; Carmen Leal; Marisa Mekkittikul; Elham Ghadishah; Bruce Teter; Harry V Vinters; Gregory Michael Cole; Sally A Frautschy Journal: Front Physiol Date: 2019-10-24 Impact factor: 4.566
Authors: Gabor G Kovacs; Sharon X Xie; John L Robinson; Edward B Lee; Douglas H Smith; Theresa Schuck; Virginia M-Y Lee; John Q Trojanowski Journal: Acta Neuropathol Commun Date: 2018-06-11 Impact factor: 7.801